India's pharma market growth remained moderate in October 2024, with a sub-5% year-on-year increase, driven by price hikes and new launches, but weighed down by weak volume growth, with key growth drivers including 📌J B Pharma, 📌Sun Pharma, and 📌Torrent Pharma, while vAlkem Labs and 📌Mankind Pharma underperformed.